PetMed Express, Inc.

Equities

PETS

US7163821066

Drug Retailers

Market Closed - Nasdaq 04:00:00 2024-06-13 pm EDT 5-day change 1st Jan Change
4.19 USD +0.48% Intraday chart for PetMed Express, Inc. -0.95% -44.58%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sector Update: Health Care Stocks Rise Premarket Wednesday MT
Top Premarket Decliners MT
Morgan Stanley Lowers Price Target on PetMed Express to $3.50 From $6.50, Maintains Underweight Rating MT
PetMed Express Fiscal Q4 Loss Widens, Net Sales Increase; Shares Fall After-Hours MT
Transcript : PetMed Express, Inc., Q4 2024 Earnings Call, Jun 11, 2024
PetMed Express, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
Earnings Flash (PETS) PETMED EXPRESS Reports Q4 Revenue $66.5M, vs. Street Est of $65M MT
PetMed Express, Inc. Announces Executive Changes CI
PetMed Express, Inc. Announces Christine Chambers Will Leave the Company in Early August 2024 CI
PetMed Express, Inc. Appoints Carla Dodds as Chief Marketing Officer CI
Petmed Express, Inc. Appoints Justin Mennen to Board of Directors, Effective June 3, 2024 CI
PetMed Express, Inc. Announces Executive Changes CI
Petmed Express, Inc. Announces CEO Changes CI
PetMed Express Appoints Sandra Campos as Chief Executive, President MT
Earnings Flash (PETS) PETMED EXPRESS Posts Q3 Revenue $65.3M MT
PetMed Express, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
PetMed Express, Inc.(NasdaqGS:PETS) dropped from NASDAQ Internet Index CI
Transcript : PetMed Express, Inc., Q3 2024 Earnings Call, Feb 08, 2024
PetMed Express Names Leslie C. G. Campbell Chairman MT
PetMed Express, Inc. Announces Management Changes CI
Morgan Stanley Trims Price Target on PetMed Express to $6.50 From $7, Keeps Underweight Rating MT
Petmed Express Insider Bought Shares Worth $301,125, According to a Recent SEC Filing MT
Petmed Express Insider Bought Shares Worth $100,551, According to a Recent SEC Filing MT
Tranche Update on PetMed Express, Inc.'s Equity Buyback Plan announced on August 1, 2011. CI
Traders Eye Fed Meeting for Fresh Cues as US Equity Futures Edge Higher Pre-Bell MT
Chart PetMed Express, Inc.
More charts
PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy. The Company is an online provider of prescription and non-prescription medications, food, supplements, supplies and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile applications. Its product line contains approximately 15,000 SKUs of pet medications, health products, and supplies. The Company offers various pet supplies, including food, beds, crates, stairs and other pet supplies. PetMeds products include Non-Prescription Medications (OTC) and supplies, and Prescription Medications (Rx). OTC and supplies include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. Rx includes heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
4.19 USD
Average target price
5.25 USD
Spread / Average Target
+25.30%
Consensus
  1. Stock Market
  2. Equities
  3. PETS Stock
  4. News PetMed Express, Inc.
  5. PetMed Express : Sidoti & Co Downgrades PetMed Express to Neutral From Buy, Keeps $39 Price Target